-
Something wrong with this record ?
Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout mice
J Myslivecek, EG Duysen, O Lockridge
Language English Country Germany
NLK
SpringerLink Journals
from 1997-01-01 to 2009-04-30
ProQuest Central
from 2007-01-01 to 2009-12-31
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2007-01-01 to 2009-12-31
- MeSH
- Acetylcholine metabolism MeSH
- Acetylcholinesterase genetics MeSH
- Receptors, Adrenergic biosynthesis MeSH
- Cyclic AMP biosynthesis MeSH
- Down-Regulation MeSH
- Financing, Organized MeSH
- Phosphatidylinositols metabolism MeSH
- Type C Phospholipases metabolism MeSH
- Immunoassay MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Lung metabolism MeSH
- GTP-Binding Proteins metabolism MeSH
- Radioligand Assay MeSH
- Receptors, Muscarinic biosynthesis MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
The acetylcholinesterase knockout mouse has elevated acetylcholine levels due to the complete absence of acetylcholinesterase. Our goal was to determine the adaptive changes in lung receptors that allow these animals to tolerate excess neurotransmitter. The hypothesis was tested that not only muscarinic receptors but also alpha(1)-adrenoceptors and beta-adrenoceptors are downregulated, thus maintaining a proper balance of receptors and accounting for lung function in these animals. The quantity of alpha(1A), alpha(1B), alpha(1D), beta(1), and beta(2)-adrenoceptors and muscarinic receptors was determined by binding of radioligands. G-protein coupling was assessed using pseudo-competition with agonists. Phospholipase C activity was measured by an enzymatic assay. Cyclic AMP (cAMP) content was measured by immunoassay. Muscarinic receptors were decreased to 50%, alpha(1)-adrenoceptors to 23%, and beta-adrenoceptors to about 50% of control. Changes were subtype specific, as alpha(1A), alpha(1B), and beta(2)-adrenoceptors, but not alpha(1D)-adrenoceptor, were decreased. In contrast, receptor signaling into the cell as measured by coupling to G proteins, cAMP content, and PI-phospholipase C activity was the same as in control. This shows that the nearly normal lung function of these animals was explained by maintenance of a correct balance of adrenoceptors and muscarinic receptors. In conclusion, knockout mice have adapted to high concentrations of acetylcholine by downregulating receptors that bind acetylcholine, as well as by downregulating receptors that oppose the action of muscarinic receptors. Tolerance to excess acetylcholine is achieved by reducing the levels of muscarinic receptors and adrenoceptors.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026370
- 003
- CZ-PrNML
- 005
- 20111210192330.0
- 008
- 101018s2007 gw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Mysliveček, Jaromír, $d 1968- $7 nlk19990073583
- 245 10
- $a Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout mice / $c J Myslivecek, EG Duysen, O Lockridge
- 314 __
- $a Institute of Physiology, 1st Faculty of Medicine, Charles University, Albertov 5, 12800 Prague, Czech Republic. jmys@lf1.cuni.cz
- 520 9_
- $a The acetylcholinesterase knockout mouse has elevated acetylcholine levels due to the complete absence of acetylcholinesterase. Our goal was to determine the adaptive changes in lung receptors that allow these animals to tolerate excess neurotransmitter. The hypothesis was tested that not only muscarinic receptors but also alpha(1)-adrenoceptors and beta-adrenoceptors are downregulated, thus maintaining a proper balance of receptors and accounting for lung function in these animals. The quantity of alpha(1A), alpha(1B), alpha(1D), beta(1), and beta(2)-adrenoceptors and muscarinic receptors was determined by binding of radioligands. G-protein coupling was assessed using pseudo-competition with agonists. Phospholipase C activity was measured by an enzymatic assay. Cyclic AMP (cAMP) content was measured by immunoassay. Muscarinic receptors were decreased to 50%, alpha(1)-adrenoceptors to 23%, and beta-adrenoceptors to about 50% of control. Changes were subtype specific, as alpha(1A), alpha(1B), and beta(2)-adrenoceptors, but not alpha(1D)-adrenoceptor, were decreased. In contrast, receptor signaling into the cell as measured by coupling to G proteins, cAMP content, and PI-phospholipase C activity was the same as in control. This shows that the nearly normal lung function of these animals was explained by maintenance of a correct balance of adrenoceptors and muscarinic receptors. In conclusion, knockout mice have adapted to high concentrations of acetylcholine by downregulating receptors that bind acetylcholine, as well as by downregulating receptors that oppose the action of muscarinic receptors. Tolerance to excess acetylcholine is achieved by reducing the levels of muscarinic receptors and adrenoceptors.
- 650 _2
- $a acetylcholin $x metabolismus $7 D000109
- 650 _2
- $a acetylcholinesterasa $x genetika $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a AMP cyklický $x biosyntéza $7 D000242
- 650 _2
- $a down regulace $7 D015536
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a proteiny vázající GTP $x metabolismus $7 D019204
- 650 _2
- $a imunoanalýza $7 D007118
- 650 _2
- $a plíce $x metabolismus $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a fosfatidylinositoly $x metabolismus $7 D010716
- 650 _2
- $a radioligandová zkouška $7 D011869
- 650 _2
- $a adrenergní receptory $x biosyntéza $7 D011941
- 650 _2
- $a receptory muskarinové $x biosyntéza $7 D011976
- 650 _2
- $a fosfolipasy typu C $x metabolismus $7 D010738
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Duysen, Ellen G.
- 700 1_
- $a Lockridge, Oksana
- 773 0_
- $w MED00003462 $t Naunyn-Schmiedeberg's archives of pharmacology $g Roč. 376, č. 1-2 (2007), s. 83-92 $x 0028-1298
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110112130310 $b ABA008
- 991 __
- $a 20110114144708 $b ABA008
- 999 __
- $a ok $b bmc $g 801475 $s 666222
- BAS __
- $a 3
- BMC __
- $a 2007 $b 376 $c 1-2 $d 83-92 $i 0028-1298 $m Naunyn-Schmiedeberg's archives of pharmacology $n Naunyn Schmiedebergs Arch Pharmacol $x MED00003462
- LZP __
- $a 2010-B/mk